Commissions defend grants, trauma funding and AHEAD preparations as advocates press to restore consortium money

The Health and Social Services Subcommittee heard a series of presentations on health regulatory bodies, the community behavioral‑health consortium grants created under the Blueprint for Maryland’s Future, trauma funding, and the state’s transition to the federal AHEAD model.

DLS analyst Anne Braun briefed the panel on the fiscal 2026 allowances for the health regulatory commissions—Maryland Health Care Commission (MHCC), Health Services Cost Review Commission (HSCRC), Community Health Resources Commission (CHRC), and the Prescription Drug Affordability Board—and highlighted several key items for the subcommittee’s attention: proposed reductions to mandated consortium funding in the governor’s BRFAA language, the state’s preparations for the federal AHEAD total‑cost‑of‑care model, changes to trauma funding tied to vehicle registration surcharges, and activity by the Prescription Drug Affordability Board.

Nut graf: Why it matters

The commissions oversee or help fund services that affect provider payments, school‑based behavioral health access, trauma center finances and drug affordability; proposed budget changes and statutory language could change how grants and provider payments are distributed across the…